Radioimmunoassays for a New Angiotensin-Converting Enzyme Inhibitor, Zabicipril, and its Active Metabolite, Zabiciprilat, in Human Plasma

Most immunoassays applied to drugs in human plasma do not use an extraction of analyte. To compensate for interferences due to plasma proteins or salts, standards are prepared in drug-free plasma. Because the concentration of plasma components varies from one subject to another, it is likely that the drug-free plasma is not representative of the potential interference in each plasma. Using two immunoassays, for a steroid (nomegestrol acetate) and a heptapeptide (BN 52080), the authors have shown that tracer binding to the antibody may vary significantly between plasma from different subjects. Intersubject variability of tracer-antibody binding was 21.6% (coefficient of variation for 25 subjects) for nomegestrol acetate. When the same plasma were spiked with the steroid at a concentration corresponding to the central part of the standard curve, the recovery was between 39 and 215%. Intersubject variability in tracer binding was lower (7.7%) for the peptide immunoassay, but still affected accuracy. The authors show that this problem is common to direct immunoassays for other drugs and must be solved in assay development.

show abstract

Effect of Variability of Plasma Interferences on the Accuracy of Drug Immunoassays

Ezan

Emmanuel²,

Valente³

et al. 1997

Therapeutic Drug Monitoring

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Radioimmunoassays for a New Angiotensin-Converting Enzyme Inhibitor, Zabicipril, and its Active Metabolite, Zabiciprilat, in Human Plasma

Cited by 1 publication

References 1 publication

Effect of Variability of Plasma Interferences on the Accuracy of Drug Immunoassays

Effect of Variability of Plasma Interferences on the Accuracy of Drug Immunoassays

Contact Info

Product

Resources

About